Cetya Therapeutics HDAC inhibitors for tumor suppression
A pioneering leader in histone deacetylase inhibitor research, focusing on largazole analogs. Cetya Therapeutics Announces Advanced Industries Award. 170,000 Colorado Grant will advance Cetyas novel targeted HDAC inhibitor program more. Cetya Therapeutics Announces STTR Grant Award. 240,000 Grant will allow evaluation of Cetyas HDAC inhibitors for treatment of sickle cell disease more. Cetya has a portfolio of over 30 analogs of largazole for evaluation in a multitude of therapeutic indications.
OVERVIEW
The web page cetya-therapeutics.com presently has a traffic ranking of zero (the lower the more users). I acquired one contacts and locations for cetya-therapeutics.com to help you reach them. The web page cetya-therapeutics.com has been online for six hundred and seventy-four weeks, two days, eleven hours, and thirty-four minutes.
Contacts
1Addresses
1Online Since
Jul 2012CETYA-THERAPEUTICS.COM TRAFFIC
The web page cetya-therapeutics.com is seeing diverging levels of traffic all through the year.
Date Range
1 week
1 month
3 months
This Year
Last Year
All time
Date Range
All time
This Year
Last Year
Date Range
All time
This Year
Last Year
Last Month
CETYA-THERAPEUTICS.COM HISTORY
The web page cetya-therapeutics.com was first documented on July 17, 2012. It was last updated on the date of May 18, 2014. This web page will go back on the market on July 17, 2015. As of today, it is six hundred and seventy-four weeks, two days, eleven hours, and thirty-four minutes young.
REGISTERED
July
2012
UPDATED
May
2014
EXPIRED
July
2015
WEBPAGE PERIOD OF EXISTANCE
12
YEARS
11
MONTHS
2
DAYS
LINKS TO WEBSITE
WHAT DOES CETYA-THERAPEUTICS.COM LOOK LIKE?
CONTACTS
PERFECT PRIVACY, LLC
12808 Gran Bay Parkway West
Jacksonville, FL, 32258
US
CETYA-THERAPEUTICS.COM SERVER
Our crawlers revealed that the main page on cetya-therapeutics.com took four thousand two hundred and sixty-three milliseconds to come up. I could not discover a SSL certificate, so I consider this site not secure.
Load time
4.263 sec
SSL
NOT SECURE
IP
73.78.99.16
NAME SERVERS
ns49.worldnic.com
ns50.worldnic.com
WEBSITE ICON
SERVER SOFTWARE AND ENCODING
We caught that cetya-therapeutics.com is weilding the Apache/2.4.7 (Ubuntu) operating system.HTML TITLE
Cetya Therapeutics HDAC inhibitors for tumor suppressionDESCRIPTION
A pioneering leader in histone deacetylase inhibitor research, focusing on largazole analogs. Cetya Therapeutics Announces Advanced Industries Award. 170,000 Colorado Grant will advance Cetyas novel targeted HDAC inhibitor program more. Cetya Therapeutics Announces STTR Grant Award. 240,000 Grant will allow evaluation of Cetyas HDAC inhibitors for treatment of sickle cell disease more. Cetya has a portfolio of over 30 analogs of largazole for evaluation in a multitude of therapeutic indications.PARSED CONTENT
The web page had the following on the web page, "A pioneering leader in histone deacetylase inhibitor research, focusing on largazole analogs." I saw that the web site said " Cetya Therapeutics Announces Advanced Industries Award." They also said " 170,000 Colorado Grant will advance Cetyas novel targeted HDAC inhibitor program more. Cetya Therapeutics Announces STTR Grant Award. 240,000 Grant will allow evaluation of Cetyas HDAC inhibitors for treatment of sickle cell disease more. Cetya has a portfolio of over 30 analogs of largazole for evaluation in a multitude of therapeutic indications."ANALYZE SUBSEQUENT BUSINESSES
Hormigones Pamplona - Fábrica y venta de Hormigón en Navarra - CETYA
Fabricamos y vendemos áridos, hormigones, morteros y revocos en silo y ensacados. Somos la empresa Navarra referente en la comercialización de áridos, hormigones, morteros y revocos.
CETYCLI.org l Centro de Estudios de TeorÃa y CrÃtica Literaria l UNR
CENTRO DE ESTUDIOS DE TEORÍA Y CRÍTICA LITERARIA. De la cual se publicaron cuatro números que pueden consultarse aquí on line. Javier Gasparri e Irina Garbatsky.
cetyeri.net
The Sponsored Listings displayed above are served automatically by a third party. Neither the service provider nor the domain owner maintain any relationship with the advertisers.